CIK 0001557746
- Non-accelerated filer
- Smaller reporting company
Aclaris Therapeutics, Inc.
Sign in to watch- Ticker
- ACRS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 460571712
- Phone
- +1 484-324-7933
- Business address
- 701 LEE ROAD, SUITE 103, WAYNE, PA, 19087
- 4 Option exercise Director acquired 4,660 shares (option exercise)
- 4 Option exercise Director acquired 4,660 shares (option exercise)
- 4 Option exercise Director acquired 4,660 shares (option exercise)
- 4 Option exercise Director acquired 4,660 shares (option exercise)
- 4 Option exercise Director acquired 4,660 shares (option exercise)
- 4 Option exercise Director acquired 4,660 shares (option exercise)
- 4 Option exercise Director acquired 4,660 shares (option exercise)
- 4 Option exercise Director acquired 4,660 shares (option exercise)
- 4 Shares withheld for taxes INTERIM PRESIDENT AND CEO gave up 2,784 shares (to pay taxes)
- 4 Shares withheld for taxes INTERIM PRESIDENT AND CEO gave up 3,224 shares (to pay taxes)
- 4 Shares withheld for taxes Interim President and CEO gave up 3,223 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Scientific Officer gave up 21,283 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 1,417 shares (to pay taxes)
- 4 Open-market buy Director bought 14,500 shares at an average $1.24 ($17,955)
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Shares withheld for taxes Chief Scientific Officer gave up 2,583 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Business Officer gave up 6,421 shares (to pay taxes)
- 4 Derivatives Options or other derivatives
- 4 Shares withheld for taxes Chief Financial Officer gave up 2,536 shares (to pay taxes)
Page 5 of 21 · 414 filings